An 80-year-old male with a previous history of thymoma and kidney cancer underwent a 18 F fluorodeoxyglucose (FDG) positron emission tomography (PET)/contrast-enhanced computed tomography (CT) scan: two pulmonary nodules were discovered, both characterized by an increased glucose uptake. Of them, only one showed mild contrast enhancement. Both nodules were surgically resected: the first nodule was a benign meningioma and the second one was a malignant meningioma. This case study shows that malignancy of meningioma in the lung is not correlated with 18 F FDG uptake and the contrast enhancement, thus suggesting that PET/CT may represent a suboptimal imaging modality for the evaluation of these lesions.
Introduction
Ectopical meningiomas (extracranial meningiomas) are extremely rare: despite being one of the most frequently diagnosed primary intracranial tumors, meningioma rarely occurs in several locations such as the head-and-neck region, skin, bone, peripheral nerves, retroperitoneum, and lung. [1, 2] Different histogenetic and pathologic mechanisms have been proposed, but the true etiology of this tumor is still uncertain: [3] Some authors believe that extracranial meningioma might derive from misplaced or migrate arachnoid cells, other investigators have revealed that the tumor may originate from perineurial cells or pluripotent mesenchymal cells. [2] The first reported case of primary pulmonary meningioma (PPM) was in 1982. [4] To the best of our knowledge, till date, only 44 cases have been reported in the literature: among these cases, only five were malignant or atypical. [1, 2] Case Report Figure 4 ]. After an atypical resection of the superior lobe of the left lung in September 2016, biopsy showed a high proliferative activity with a number of mitotic figures >20/10 HPF, Ki-67 ≈ 20%, with associated necrosis and on immunohistochemistry cells expressed epithelial membrane antigen and they were positive for vimentin and progesterone: the final diagnosis was anaplastic meningioma (malignant).
Discussion
To the best of our knowledge, this is the first 18 F FDG PET/CT evaluation of a patient with synchronous benign and malignant PPM, with similar dimensions (14 and 12 mm in diameter): qualitative and semi-quantitative (SUVmax) analysis with PET suggested less metabolic activity in malignant PPM, with more intense uptake of 18 F FDG in fibrotic PPM. Furthermore, anaplastic meningioma showed enhancement with iodinated contrast media. From this case report, we conclude that 18 F FDG PET may not suffice in the evaluations of patients with PPM; the conjunction with contrast-enhanced CT may help in the discrimination between malign and benign lesions. Furthermore, due to high levels of expression of the somatostatin receptor subtype 2 in meningiomas, the use of other radiolabeled compounds (i.e., 68 Ga-DOTATOC PET/CT [1, 5] ) may be more useful for this aim.
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